Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2025 03:00 ET | Source: Onco3R Therapeutics BV

Onco3R Therapeutics reports first pre-clinical data from its best-in-class precision oncology portfolio at the 2025 AACR-NCI-EORTC symposium

Three posters to be presented featuring pre-clinical data of potential best-in-class FGFR3 selective inhibitor, SMARCA2 selective inhibitor, and P53 Y220C reactivatorCandidates for FGFR3 and SMARCA2...
October 06, 2025 03:00 ET | Source: Onco3R Therapeutics BV

Onco3R Therapeutics Announces Completion of First Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671 and Oral Presentation at UEGW 2025

Dosing of first cohort in Phase 1 trial of O3R-5671 complete with no adverse findings On track for full data read out in the first half of 2026 Discovery and preclinical data on O3R-5671...
September 30, 2025 08:45 ET | Source: Nuwellis, Inc.

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

ULTRA-Peds Registry Demonstrate 92% Treatment Survival in Children with AKI Fluid Overload or Congenital Kidney Failure
September 26, 2025 11:08 ET | Source: Spherix Global Insights

Spherix Global Insights Highlights Patient Influence in Shaping PNH Treatment Choices

EXTON, Pa., Sept. 26, 2025 (GLOBE NEWSWIRE) -- Spherix Global Insights today announced the latest quarterly update to its RealTime Dynamix™: Paroxysmal Nocturnal Hemoglobinuria (PNH) service,...
September 16, 2025 11:20 ET | Source: Steadman Philippon Research Institute

NIH-Funded Study Launches at SPRI to Advance Shoulder Repair Techniques

VAIL, Colorado, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI), in collaboration with the University of Texas Health Science Center at Houston (UTHealth), has...
September 04, 2025 08:30 ET | Source: Oncotelic Therapeutics, Inc.

Dr. Vuong Trieu, Developer of Novel Oncology and Immunotherapy Assets, Leads Oncotelic Therapeutics’ Commitment to Innovation, Life-Saving Therapies

Dr. Trieu’s prolific career includes multibillion-dollar drug discoveries targeting cancers of the breast, pancreas and non-small cell lung cancer, among others Oncotelic’s robust portfolio and...
September 04, 2025 07:30 ET | Source: A Race Against Blindness

A Race Against Blindness Awards Additional $1 Million Grant to Advance Clinical Trial for Sight-Saving Gene Therapy for Bardet-Biedl Syndrome 1 (BBS1)

PHOENIX, Sept. 04, 2025 (GLOBE NEWSWIRE) -- A Race Against Blindness, the Arizona-based 501(c)(3) nonprofit founded by Dr. Stephen Johnston and Kristina Johnston, announced today that it has awarded...
September 02, 2025 08:00 ET | Source: Steadman Philippon Research Institute

Department of Defense (DoD) Awards Nearly $1 Million to Steadman Philippon Research Institute (SPRI) for Breakthrough Study on Extracellular Vesicles Therapeutic for Joint Regeneration

VAIL, Colorado / BASALT, Colorado, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The U.S. Department of Defense (DoD) has awarded a $962,977 contract to Steadman Philippon Research Institute (SPRI) to launch a...
August 28, 2025 08:10 ET | Source: Seluna Ltd

Scottish Medtech Seluna Launches Pediatric Sleep Trial Ahead of U.S. Entry

Glasgow, UK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Scottish Medtech Seluna Launches Pediatric Sleep Trial Ahead of U.S. Entry Seluna seeks US collaborations and investment to transform childhood...
July 21, 2025 08:14 ET | Source: Urteste S.A.

Urteste S.A. Completes Development of Panuri Test – Company Plans to Launch Clinical Study in Q3 2025

Urteste S.A. Completes Development of Panuri Test – Company Plans to Launch Clinical Study in Q3 2025 Gdańsk, Poland - July 21, 2025 - Urteste S.A. (Warsaw Stock Exchange: URT), a company...